181 related articles for article (PubMed ID: 1685836)
21. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
Bauer J; Bastian BC
Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
[TBL] [Abstract][Full Text] [Related]
22. [The importance of flow cytometry and the cell proliferation index in choroidal melanoma].
Ranty ML; Quintyn JC; Courville P; Brasseur G
J Fr Ophtalmol; 2003 Sep; 26(7):725-9. PubMed ID: 13130261
[TBL] [Abstract][Full Text] [Related]
23. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
[TBL] [Abstract][Full Text] [Related]
24. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
[TBL] [Abstract][Full Text] [Related]
25. Significance of DNA ploidy measurements in Spitz nevi.
Skowronek J; Warchoł JB; Karaś Z; Krenz RM
Pol J Pathol; 2000; 51(1):45-50. PubMed ID: 10833903
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometry and prognostic implications in patients with solid tumors.
Williams NN; Daly JM
Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
[TBL] [Abstract][Full Text] [Related]
28. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1979 Mar; 87A(2):131-8. PubMed ID: 433595
[TBL] [Abstract][Full Text] [Related]
29. Differences in chromosomal aberrations between nodular and superficial spreading malignant melanoma detected by interphase cytogenetics.
Poetsch M; Woenckhaus C; Dittberner T; Pambor M; Lorenz G; Herrmann FH
Lab Invest; 1998 Jul; 78(7):883-8. PubMed ID: 9690566
[TBL] [Abstract][Full Text] [Related]
30. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
31. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
[TBL] [Abstract][Full Text] [Related]
32. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
[TBL] [Abstract][Full Text] [Related]
33. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.
Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG
Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980
[TBL] [Abstract][Full Text] [Related]
34. Malignant melanoma in children and congenital melanocytic nevi: DNA content and cell cycle analysis by flow cytometry.
Alvarez-Mendoza A; Reyes-Esparza J; Ruiz-Maldonado R; Lopez-Corella E; Juarez-Herrera NC
Pediatr Dev Pathol; 2001; 4(1):73-81. PubMed ID: 11200494
[TBL] [Abstract][Full Text] [Related]
35. Single cell DNA cytophotometry in clinical stage I malignant melanoma. Relationship to prognosis.
Lindholm C; Hofer PA; Jonsson H
Acta Oncol; 1990; 29(2):147-50. PubMed ID: 2334568
[TBL] [Abstract][Full Text] [Related]
36. P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study.
Talve LA; Collan YU; Ekfors TO
Anal Quant Cytol Histol; 1997 Oct; 19(5):393-403. PubMed ID: 9349899
[TBL] [Abstract][Full Text] [Related]
37. Subungual pigmented nevus: evaluation of DNA ploidy in six cases.
Asahina A; Chi HI; Otsuka F
J Dermatol; 1993 Aug; 20(8):466-72. PubMed ID: 8245307
[TBL] [Abstract][Full Text] [Related]
38. Small malignant melanomas: clinicopathologic correlation and DNA ploidy analysis.
Kamino H; Kiryu H; Ratech H
J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1032-8. PubMed ID: 2370327
[TBL] [Abstract][Full Text] [Related]
39. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
[TBL] [Abstract][Full Text] [Related]
40. DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course.
Søndergaard K; Larsen JK; Møller U; Christensen IJ; Hou-Jensen K
Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 42(1):43-52. PubMed ID: 6132488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
